IRMD vs MSFT: Which Stock is Better?
Side-by-side comparison of Iradimed Corp and Microsoft Corp in 2026
IRMD
Iradimed Corp
$93.05
MSFT
Microsoft Corp
$418.00
Key Metrics Comparison
| Metric | IRMD | MSFT | Winner |
|---|---|---|---|
| Market Cap | $1.20B | N/A | IRMD |
| P/E Ratio | 53.46 | 24.57 | MSFT |
| EPS (TTM) | $1.75 | $16.00 | MSFT |
| Revenue Growth | 0.2% | 0.2% | IRMD |
| Gross Margin | 76.7% | 68.6% | IRMD |
Analyze IRMD
Full quant analysis
Analyze MSFT
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is IRMD or MSFT a better investment?
Comparing IRMD and MSFT: Iradimed Corp has a market cap of $1.20B while Microsoft Corp has N/A. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between IRMD and MSFT?
IRMD (Iradimed Corp) and MSFT (Microsoft Corp) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: IRMD or MSFT?
Based on P/E ratios, MSFT trades at a lower multiple (24.6x vs 53.5x).
Which is growing faster: IRMD or MSFT?
IRMD has higher revenue growth at 0.2% vs 0.2% for MSFT.
Which company is more profitable: IRMD or MSFT?
Iradimed Corp (IRMD) has higher gross margins at 76.7% compared to 68.6% for MSFT.
Which is the larger company: IRMD or MSFT?
Iradimed Corp (IRMD) is larger with a market cap of $1.20B compared to N/A for MSFT.
Should I buy IRMD or MSFT in 2026?
Both IRMD and MSFT have investment merit. IRMD trades at $93.05 while MSFT trades at $418.00. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between IRMD and MSFT stock?
Key differences: Market Cap ($1.20B vs N/A), P/E Ratio (53.5x vs 24.6x), Revenue Growth (0.2% vs 0.2%), Gross Margin (76.7% vs 68.6%).